251 related articles for article (PubMed ID: 24603599)
1. An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.
Li Y; Chen JA; Sears RL; Gao F; Klein ED; Karydas A; Geschwind MD; Rosen HJ; Boxer AL; Guo W; Pellegrini M; Horvath S; Miller BL; Geschwind DH; Coppola G
PLoS Genet; 2014 Mar; 10(3):e1004211. PubMed ID: 24603599
[TBL] [Abstract][Full Text] [Related]
2. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.
Yokoyama JS; Karch CM; Fan CC; Bonham LW; Kouri N; Ross OA; Rademakers R; Kim J; Wang Y; Höglinger GU; Müller U; Ferrari R; Hardy J; ; Momeni P; Sugrue LP; Hess CP; James Barkovich A; Boxer AL; Seeley WW; Rabinovici GD; Rosen HJ; Miller BL; Schmansky NJ; Fischl B; Hyman BT; Dickson DW; Schellenberg GD; Andreassen OA; Dale AM; Desikan RS
Acta Neuropathol; 2017 May; 133(5):825-837. PubMed ID: 28271184
[TBL] [Abstract][Full Text] [Related]
3. Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders.
Webb A; Miller B; Bonasera S; Boxer A; Karydas A; Wilhelmsen KC
Arch Neurol; 2008 Nov; 65(11):1473-8. PubMed ID: 19001166
[TBL] [Abstract][Full Text] [Related]
4. Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants.
Razquin C; Ortega-Cubero S; Rojo-Bustamante E; Diez-Fairen M; Lorenzo E; Alonso E; Ezquerra M; Ross OA; Carcel M; Lorenzo-Betancor O; Soto AI; Burgess JD; Ertekin-Taner N; Dickson DW; Pastor MA; Tolosa E; Pastor P
Neurobiol Aging; 2018 Jun; 66():177.e7-177.e10. PubMed ID: 29398119
[TBL] [Abstract][Full Text] [Related]
5. VEGF haplotypes are associated with increased risk to progressive supranuclear palsy and corticobasal syndrome.
Borroni B; Del Bo R; Goldwurm S; Archetti S; Bonvicini C; Agosti C; Bigni B; Papetti A; Ghezzi S; Sacilotto G; Pezzoli G; Gennarelli M; Bresolin N; Comi GP; Padovani A
J Alzheimers Dis; 2010; 21(1):87-94. PubMed ID: 20413880
[TBL] [Abstract][Full Text] [Related]
6. Further extension of the H1 haplotype associated with progressive supranuclear palsy.
Pastor P; Ezquerra M; Tolosa E; Muñoz E; Martí MJ; Valldeoriola F; Molinuevo JL; Calopa M; Oliva R
Mov Disord; 2002 May; 17(3):550-6. PubMed ID: 12112206
[TBL] [Abstract][Full Text] [Related]
7. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
[TBL] [Abstract][Full Text] [Related]
8. Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.
Borroni B; Agosti C; Magnani E; Di Luca M; Padovani A
Curr Med Chem; 2011; 18(17):2655-60. PubMed ID: 21568901
[TBL] [Abstract][Full Text] [Related]
9. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
Höglinger GU; Melhem NM; Dickson DW; Sleiman PM; Wang LS; Klei L; Rademakers R; de Silva R; Litvan I; Riley DE; van Swieten JC; Heutink P; Wszolek ZK; Uitti RJ; Vandrovcova J; Hurtig HI; Gross RG; Maetzler W; Goldwurm S; Tolosa E; Borroni B; Pastor P; ; Cantwell LB; Han MR; Dillman A; van der Brug MP; Gibbs JR; Cookson MR; Hernandez DG; Singleton AB; Farrer MJ; Yu CE; Golbe LI; Revesz T; Hardy J; Lees AJ; Devlin B; Hakonarson H; Müller U; Schellenberg GD
Nat Genet; 2011 Jun; 43(7):699-705. PubMed ID: 21685912
[TBL] [Abstract][Full Text] [Related]
10. Survival in progressive supranuclear palsy and frontotemporal dementia.
Chiu WZ; Kaat LD; Seelaar H; Rosso SM; Boon AJ; Kamphorst W; van Swieten JC
J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):441-5. PubMed ID: 20360166
[TBL] [Abstract][Full Text] [Related]
11. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
12. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
[TBL] [Abstract][Full Text] [Related]
13. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.
Pastor P; Ezquerra M; Perez JC; Chakraverty S; Norton J; Racette BA; McKeel D; Perlmutter JS; Tolosa E; Goate AM
Ann Neurol; 2004 Aug; 56(2):249-58. PubMed ID: 15293277
[TBL] [Abstract][Full Text] [Related]
14. Progressive supranuclear palsy in a family with TDP-43 pathology.
Kertesz A; Finger E; Murrell J; Chertkow H; Ang LC; Baker M; Ravenscroft T; Rademakers R; Munoz DG
Neurocase; 2015; 21(2):178-84. PubMed ID: 24479957
[TBL] [Abstract][Full Text] [Related]
15. Familial aggregation of parkinsonism in progressive supranuclear palsy.
Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
[TBL] [Abstract][Full Text] [Related]
16. The MAPT gene is differentially methylated in the progressive supranuclear palsy brain.
Huin V; Deramecourt V; Caparros-Lefebvre D; Maurage CA; Duyckaerts C; Kovari E; Pasquier F; Buée-Scherrer V; Labreuche J; Behal H; Buée L; Dhaenens CM; Sablonnière B
Mov Disord; 2016 Dec; 31(12):1883-1890. PubMed ID: 27709663
[TBL] [Abstract][Full Text] [Related]
17. Unraveling progressive supranuclear palsy: from the bedside back to the bench.
Houghton DJ; Litvan I
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S341-6. PubMed ID: 18267262
[TBL] [Abstract][Full Text] [Related]
18. A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.
Chen JA; Wang Q; Davis-Turak J; Li Y; Karydas AM; Hsu SC; Sears RL; Chatzopoulou D; Huang AY; Wojta KJ; Klein E; Lee J; Beekly DL; Boxer A; Faber KM; Haase CM; Miller J; Poon WW; Rosen A; Rosen H; Sapozhnikova A; Shapira J; Varpetian A; Foroud TM; Levenson RW; Levey AI; Kukull WA; Mendez MF; Ringman J; Chui H; Cotman C; DeCarli C; Miller BL; Geschwind DH; Coppola G
JAMA Neurol; 2015 Apr; 72(4):414-22. PubMed ID: 25706306
[TBL] [Abstract][Full Text] [Related]
19. Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy.
de Silva R; Weiler M; Morris HR; Martin ER; Wood NW; Lees AJ
Neurosci Lett; 2001 Oct; 311(3):145-8. PubMed ID: 11578815
[TBL] [Abstract][Full Text] [Related]
20. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
